Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruct
暂无分享,去创建一个
E. Tuzcu | Alfonso T. Perez | S. Nissen | A. Lavoie | S. Nicholls | R. Nesto | S. Kupfer | K. Wolski | S. Nissen | K. Uno | O. Bayturan | A. Perez | Stephen J. Nicholls